ADHD Market to Reach Nearly $13.9 Billion by 2024

According to research and consulting firm GlobalData, the market for ADHD (attention deficit hyperactivity disorder) is set to experience a raise from about $6.1 billion in 2014 to $13.9 billion by 2024, across different markets of the UK, Germany, Japan, US, France, Spain, and Italy. The GlobalData’s new report states that this great increase can be attributed to the commence of the efficient pipeline products with less dosing as compared to the products that are available today. Researchers are even discussing the ongoing link between squirming and learning, and strategies to deal with ADHD.

Rachel Markwick, Ph.D., who is an analyst at GlobalData stated that presently the ADHD market is spreading with unmet needs. These needs also include the requirement for more options for treatments, improved diagnostic tests, recognition and increased education of ADHD. You might have heard about Ritalin, which is the famous ADHD treatment, is available from 1956. It was introduced by Central Institute of Brackishwater Aquaculture (CIBA). ADHD patients were often seen by pediatricians; they accounted for fifty-seven percent, primary care physicians accounted for thirteen percent and psychiatrists accounted for twenty-nine percent of physician visits for this condition.

There is no doubt that the growth of the ADHD market is remarkable and during the past five years, it has grown about forty-five percent. Well, ADHD products are categorized as Schedule II controlled substances. The point is late-stage pipeline treatments are expected to be the main player in the ADHD market. It is made to treat a specific kind of symptoms like impulsive aggression. Also, SHP-456, which is a late-stage pipeline asset was made to extend ADHD symptom coverage into the evening. Its commercial success would come in the mainstream by the fact that it has been created to last for sixteen hours. When it comes to Adderall XR, which is its predecessor, it lasts for twelve hours only.

The late-stage pipeline has several stimulant formations that give multiple options with extended coverage of ADHD symptoms along with the convenient dosage forms. If you have more questions or want to take other exciting quizzes, then feel free to explore HealthIQ.com.